Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …

The epidemic of type 2 diabetes in the latter part of the 20th and in the early 21st century,
and the recognition that achieving specific glycaemic goals can substantially reduce …

The epidemic of type 2 diabetes in the latter part of the 20th and in the early 21st century,
and the recognition that achieving specific glycemic goals can substantially reduce …

In 2012, the American Diabetes Association (ADA) and the European Association for the
Study of Diabetes (EASD) published a position statement on the management of …

Moderate aLimited use in the US/Europe. bNot licensed in the US cPrescribing highly
restricted in the US; withdrawn in Europe. dNot licensed in Europe. eTo be available as a …

Diabetologia (2015) 58: 429–442 DOI 10.1007/s00125-014-3460-0 management of
hyperglycaemia in patients with type 2 diabetes [1, 2]. This was needed because of an …

Key Clinical Points Glycemic Control in Type 2 Diabetes Mellitus Intensive glycemic control
reduces the risk of microvascular complications of type 2 diabetes, but the effect of strict …

Current guidelines for treating patients with type 2 diabetes mellitus are based on glycemic
standards derived from epidemiologic data; however, the course of the disease, from …

Diabetes mellitus is associated with significant morbidity and mortality derived from long-
term microvascular and macrovascular complications of chronic hyperglycemia. The …

In the management of diabetes mellitus, one of the most important goals is to prevent its
micro-and macrovascular complications, and to that end, multifactorial intervention is widely …